Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kristen A. Deger
Observed names:
Deger, Kristen A.,
Kristen A Deger,
Kristen Deger
Institution:
Thermo Fisher Scientific (United States)
Observed institutions:
Bristol-Myers Squibb (United States),
Sağlık Bilimleri Üniversitesi,
Thermo Fisher Scientific (United States),
Institutul Clinic Fundeni,
The Ohio State University
ORCID:
0000-0001-7555-8736
Observed ORCID:
0000-0001-7555-8736
OpenAlex ID:
A5103843245
Public health impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States
2022
·
Manuela Di Fusco
, Kinga Marczell
, et al.
·
Journal of Medical Economics
·
46
PDF
Health state utilities associated with attributes of migraine preventive treatments based on patient and general population preferences
2019
·
Louis S. Matza
, Kristen A. Deger
, et al.
·
Quality of Life Research
·
39
PDF
Outcomes and costs of remote patient monitoring among patients with implanted cardiac defibrillators: An economic model based on the PREDICT RM database
2019
·
James P. Hummel
, Robert J. Leipold
, et al.
·
Journal of Cardiovascular Electrophysiology
·
28
PDF
Cost-Effectiveness of Lisocabtagene Maraleucel Versus Axicabtagene Ciloleucel and Tisagenlecleucel in the Third-Line or Later Treatment Setting for Relapsed or Refractory Large B-cell Lymphoma in the United States
2023
·
Christopher Parker
, Fei Fei Liu
, et al.
·
Advances in Therapy
·
22
PDF
Qualitative Thematic Analysis of Social Media Data to Assess Perceptions of Route of Administration for Antiretroviral Treatment among People Living with HIV
2020
·
Louis S. Matza
, Trena M. Paulus
, et al.
·
Patient
·
16
PDF
Modeling the trade-off between transmissibility and contact in infectious disease dynamics
2016
·
Chiu-Ju Lin
, Kristen A. Deger
, et al.
·
Mathematical Biosciences
·
16
PDF
Health state utilities associated with treatment options for acute myeloid leukemia (AML)
2019
·
Louis S. Matza
, Kristen A. Deger
, et al.
·
Journal of Medical Economics
·
15
PDF
Cost-effectiveness analysis of dabigatran versus rivaroxaban for stroke prevention in patients with non-valvular atrial fibrillation using real-world evidence in elderly US Medicare beneficiaries
2017
·
Siyang Peng
, Kristen A. Deger
, et al.
·
Current Medical Research and Opinion
·
10
Modeling potential cost‐effectiveness of tirzepatide versus lifestyle modification for patients with overweight and obesity
2025
·
Meredith M. Hoog
, Hong Kan
, et al.
·
Obesity
·
9
PDF
A Simulation Model to Evaluate the Potential Impact of Disease-Modifying Treatments on Burden of Illness in Alzheimer’s Disease
2022
·
Amir Abbas Tahami Monfared
, Ali Tafazzoli
, et al.
·
Neurology and Therapy
·
9
PDF
Cost-Effectiveness of Lisocabtagene Maraleucel (liso-cel) Versus Axicabtagene Ciloleucel (axi-cel) for Treatment of Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)
2021
·
Christopher Parker
, Fei Fei Liu
, et al.
·
Blood
·
3
Cost-Effectiveness of Lisocabtagene Maraleucel Versus Axicabtagene Ciloleucel as Second-Line Treatment for Large B Cell Lymphoma in the United States
2026
·
Kristen A. Deger
, Fei Fei Liu
, et al.
·
Advances in Therapy
PDF
CT-107 Cost-Effectiveness of the Chimeric Antigen Receptor (CAR) T-Cell Treatments, Lisocabtagene Maraleucel (liso-cel) Versus Axicabtagene Ciloleucel (axi-cel), as Second-Line (2L) Treatment of Large B-Cell Lymphoma (LBCL)
2023
·
Matthew Lunning
, Kristen A. Deger
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: CT-107 Cost-Effectiveness of the Chimeric Antigen Receptor (CAR) T-Cell Treatments, Lisocabtagene Maraleucel (liso-cel) Versus Axicabtagene Ciloleucel (axicel), as Second-Line (2L) Treatment of Large B-Cell Lymphoma (LBCL)
2023
·
Matthew Lunning
, Kristen A. Deger
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
2496. Qualitative Thematic Analysis of Social Media Data to Assess Perceptions of Daily Oral and Long-Acting Injectable Antiretroviral Treatment among People Living with HIV
2019
·
Louis S Matza
, Trena Paulus
, et al.
·
Open Forum Infectious Diseases
PDF
Modeling the Tradeoff between Transmission and Movement in Infectious Disease Dynamics
2014
·
Kristen A. Deger
·
OhioLink ETD Center (Ohio Library and Information Network)
Show more works
View as search
Works count:
18
Citation count:
213
H-index:
9
I10-index:
8
Year
Topic
Type